Description
The 30th American College of Medical Genetics and
Genomics (ACMG) Annual Clinical Genetics Meeting took
place in Toronto, Canada, from 12th–16th March 2024.
Attended by geneticists from around the world, this year’s
meeting saw achondroplasia on the programme in the
form of a debate featuring Dr Janet Legare and Dr Julie
Hoover-Fong discussing whether all patients should be
started on vosoritide▼.
We have highlighted the key abstracts from the congress,
focusing on achondroplasia and new clinical data on
vosoritide, real-world analysis of double heterozygosity
in skeletal dysplasia, and the importance of genetic
counselling in helping families make informed decisions
during prenatal diagnostic testing.
We hope you find this selection of summaries useful!
The Achondroplasia Team
EUCAN-VOX-00431 05/24
